| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Contineum Therapeutics, Inc. | Chief Financial Officer | Stock Option (right to buy) | 192,000 | 30 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CTNM | Contineum Therapeutics, Inc. | 30 Jan 2026 | 1 | $0 | 4 | Chief Financial Officer | 30 Jan 2026, 16:57 |
| CTNM | Contineum Therapeutics, Inc. | 31 Jan 2025 | 1 | $0 | 4 | Chief Financial Officer | 31 Jan 2025, 16:40 |
| CTNM | Contineum Therapeutics, Inc. | 24 May 2024 | 1 | $0 | 4 | Chief Financial Officer | 29 May 2024, 17:58 |
| CTNM | Contineum Therapeutics, Inc. | 04 Apr 2024 | 0 | $0 | 3 | Chief Financial Officer | 04 Apr 2024, 17:52 |